Rabdoternin F exhibits potential biological activity, particularly in preliminary studies related to anti-inflammatory and cytotoxic effects. It has been investigated for its ability to modulate cellular pathways involved in inflammation and cancer progression. Research suggests it may inhibit certain pro-inflammatory mediators, making it a candidate for further study in inflammatory diseases. Additionally, its cytotoxic properties against specific cancer cell lines indicate possible utility in oncology drug development, though it remains in early experimental stages. Applications are currently limited to laboratory and pharmacological research due to its natural scarcity and lack of clinical data.